Study Aims to Identify Drugs That Could Be Repurposed for COVID-19
Apr 15 2020
The National Institute of Allergy and Infectious Diseases (NIAID) recently launched a study to determine whether drugs that are already approved or in the late stage of clinical development might merit testing in larger clinical trials as a coronavirus disease 2019 (COVID-19) treatment.